Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine

The Journal of Pediatrics

Volumn 127, Issue 4, 1995, Pages 518-525

  Krause, Philip R ^a   Klinman, Dennis M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

CHICKENPOX; DISEASE CONTROL; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOGENICITY; PLAQUE FORMING CELL; PRIORITY JOURNAL; REVIEW; SAFETY;

CHICKENPOX; CHILD, PRESCHOOL; HEALTH PROMOTION; HERPESVIRUS 3, HUMAN; HUMAN; INFANT; INFANT, NEWBORN; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 0028882159     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(95)70106-0     Document Type: Article

References (39)

1. Cost-effectiveness of a routine varicella vaccination program for U.S. children
2. The epidemiology of varicella-zoster virus infections: a mathematical model
3. Varicella Vaccine
4. Live vaccine used to prevent the spread of varicella in children in hospital
5. Live attenuated varicella virus vaccine
6. Lengthy tale of varicella vaccine development finally nears a clinically useful conclusion
7. Status of varicella vaccine for healthy children
8. Molecular epidemiology of live attentuated varicella virus vaccine in children with leukemia and in normal adults
9. Vaccination against varicella
10. Modification of chickenpox in family contacts by administration of gamma globulin
11. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response
12. Clinical survey of natural varicella compared with breakthrough varicella after immunization with Live Attentuated Oka/Merck Varicella Vaccine
13. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine
14. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster using purified VZV glycoprotein antigen
15. Immunization against chickenpox
16. Current status and prospects of live varicella vaccine
17. Varicella-zoster virus prevalence in Japan: no significant change in a decade
18. Varicella vaccine for healthy children
19. Live attenuated varicella vaccine: evidence that the virus is atteunuated and the importance of skin lesions in transmission of varicella-zoster virus
20. Vaccines for varicella-zoster virus and cytomegalovirus: recent progress
21. Hell's fire and varicella vaccine safety
22. The risk of zoster after varicella vaccination in children with leukemia
23. Zoster in normal children after varicella vaccine
24. Epidemiology of herpes zoster in children and adolescents: a population-based study
25. Report of the Ad Hoc Committee on Karyological Control of Human Cell Substrates
26. Forty-fourth Report. Annex 1: Requirements for varicella vaccine (live)
27. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine
28. Worldwide experience with the Oka strain live varicella vaccine
29. Summary of clinical studies with the Oka live varicella vaccine produced by SmithKline-RIT
30. Childhood vaccination against chickenpox: an analysis of benefits and costs
31. Routine childhood varicella vaccination
32. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States
33. The nature of herpes zoster: a long-term study and a new hypothesis
34. Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults
35. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster
36. Live attentuated varicella vaccine: protection in healthy adults compared with leukemic children
37. Viral vaccines of the future
38. Live attenuated varicella vaccine